Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2006 | 12-2005 | |
| Operating Expenses | 108,160 | 65,400 | 24,002 | 0 | 0 |
| Operating Income | -108,160 | -65,400 | -24,002 | N/A | N/A |
| Other Income | 4,719 | 529 | 65 | 0 | 0 |
| Pre-tax Income | -103,441 | -64,871 | -23,937 | 0 | 0 |
| Income Tax | -214 | 2 | 36 | N/A | N/A |
| Net Income Continuous | -103,227 | -64,873 | -23,973 | N/A | N/A |
| Net Income | $-103,227 | $-64,873 | $-23,973 | $N/A | $N/A |
| EPS Basic Total Ops | -3.49 | -35.85 | -91.61 | N/A | N/A |
| EPS Basic Continuous Ops | -3.49 | -35.84 | -91.61 | N/A | N/A |
| EPS Diluted Total Ops | -3.49 | -35.85 | -91.61 | N/A | N/A |
| EPS Diluted Continuous Ops | -3.49 | -35.84 | -91.61 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -3.49 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-107,874 | $-65,372 | $-23,980 | $N/A | $N/A |